Tissue factor with age-related macular degeneration

Area of Science:

• Ophthalmology
• Vascular Biology
• Regenerative Medicine

Background:

• Wet age-related macular degeneration (AMD) is a significant cause of irreversible vision loss, with increasing incidence globally.
• Current treatments for wet AMD offer limited efficacy and suboptimal outcomes for many patients.
• Choroidal neovascularization (CNV) is a hallmark of wet AMD, driving disease progression.

Purpose of the Study:

• To review the current literature on wet age-related macular degeneration (AMD).
• To explore the role of tissue factors in the pathogenesis of choroidal neovascularization (CNV) in wet AMD.
• To evaluate tissue factors as potential therapeutic targets for wet AMD.

Main Methods:

• Comprehensive literature search of scientific databases (e.g., PubMed, Scopus).
• Review of studies investigating the expression and function of tissue factors in ocular tissues.
• Analysis of research on therapeutic strategies targeting tissue factors in preclinical and clinical models of wet AMD.

Main Results:

• Abnormally high expression of specific tissue factors has been consistently observed in choroidal neovascularization (CNV) associated with wet AMD.
• These tissue factors play a crucial role in promoting angiogenesis and vascular leakage in the CNV.
• Preclinical studies suggest that targeting these tissue factors can inhibit CNV formation and progression.

Conclusions:

• Tissue factors represent a promising therapeutic target for the treatment of wet age-related macular degeneration (AMD).
• Further research and clinical trials are warranted to validate the efficacy and safety of anti-tissue factor therapies for wet AMD.
• Targeting tissue factors may offer a novel strategy to improve outcomes for patients suffering from this blinding eye disease.